Dynavax Technologies Corp. (DVAX)
10.88
-0.08
(-0.77%)
USD |
NASDAQ |
Dec 09, 16:00
10.88
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies Profit Margin (Quarterly): 28.38% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | 33.68% |
| Vanda Pharmaceuticals, Inc. | -40.15% |
| ADMA Biologics, Inc. | 27.14% |
| Aldeyra Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.65% |
| Return on Assets | -4.47% |
| Return on Invested Capital | -5.15% |
| Gross Profit Margin (Quarterly) | 84.82% |
| Operating Margin (Quarterly) | 22.42% |
| Return on Net Operating Assets | -20.71% |